Naoya Ohmori Selected Research

Intraperitoneal Injections

1/2015

A novel anti-histone H1 monoclonal antibody, SSV monoclonal antibody, improves lung injury and survival in a mouse model of lipopolysaccharide-induced sepsis-like syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoya Ohmori Research Topics

Disease

1	COVID-19 10/2021
1	Skin Neoplasms (Skin Cancer) 10/2021
1	Allergic Rhinitis 01/2016
1	Lung Injury 01/2015
1	Infections 01/2015
1	Inflammation (Inflammations) 01/2015
1	Sepsis (Septicemia) 01/2015
1	Autoimmune Hepatitis 04/2010
1	Hepatitis 04/2010
1	Neoplasms (Cancer) 05/2005

Drug/Important Bio-Agent (IBA)

3	Histones (Histone)IBA 01/2016 - 04/2010
1	Stratospheric OzoneIBA 10/2021
1	Cholecalciferol (Vitamin D3)FDA Link 10/2021
1	aluminum sulfate (alum)IBA 01/2016
1	ovalbumin-alumIBA 01/2016
1	Neutralizing AntibodiesIBA 01/2016
1	Monoclonal AntibodiesIBA 01/2015
1	LipopolysaccharidesIBA 01/2015
1	NF-kappa B (NF-kB)IBA 04/2010
1	CalcineurinIBA 04/2010
1	Mitogen-Activated Protein KinasesIBA 04/2010
1	Concanavalin AIBA 04/2010
1	AutoantibodiesIBA 04/2010
1	Interleukin-12 (IL 12)IBA 05/2005

Therapy/Procedure

1	Phototherapy (Light Therapy) 10/2021
1	Intraperitoneal Injections 01/2015
1	Immunotherapy 05/2005
1	Therapeutics 05/2005